Phreesia, Inc. (PHR)
NYSE: PHR · Real-Time Price · USD
26.00
-1.17 (-4.31%)
At close: Mar 28, 2025, 4:00 PM
25.98
-0.02 (-0.07%)
After-hours: Mar 28, 2025, 8:00 PM EDT

Company Description

Phreesia, Inc. engages in the provision of an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.

The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

It deploys its platform in a range of modalities, including Phreesia Mobile, a patients’ mobile device; PhreesiaPads, a self-service intake tablets; Phreesia Dashboard, a web-based dashboard for healthcare services clients; and Arrivals Kiosks, which are on-site kiosks.

The company serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies.

Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

Phreesia, Inc.
Phreesia logo
Country United States
Founded 2005
IPO Date Jul 18, 2019
Industry Health Information Services
Sector Healthcare
Employees 2,082
CEO Chaim Indig

Contact Details

Address:
1521 Concord Pike, Suite 301
Wilmington, Delaware 19803
United States
Phone 888 654 7473
Website phreesia.com

Stock Details

Ticker Symbol PHR
Exchange NYSE
Stock Type Common Stock
Fiscal Year February - January
Reporting Currency USD
IPO Price $17.00
CIK Code 0001412408
CUSIP Number 71944F106
ISIN Number US71944F1066
SIC Code 7389

Key Executives

Name Position
Chaim Indig Co-Founder, Chief Executive Officer and Director
Evan Roberts Co-Founder and Chief Operating Officer
Balaji Gandhi Chief Financial Officer
Allison C. Hoffman J.D. General Counsel and Secretary
David Linetsky Senior Vice President of Life Sciences
Yvonne Hui Vice President and Principal Accounting Officer
Jack Callahan Chief Technology Officer
Maureen McKinney Vice President of Corporate Communications
Amy Beth VanDuyn Senior Vice President of Human Resources
Melissa Mitchell Chief Privacy Officer

Latest SEC Filings

Date Type Title
Mar 26, 2025 144 Filing
Mar 19, 2025 144 Filing
Mar 18, 2025 144 Filing
Mar 17, 2025 144 Filing
Mar 13, 2025 S-8 Securities to be offered to employees in employee benefit plans
Mar 13, 2025 10-K Annual Report
Mar 12, 2025 8-K Current Report
Feb 19, 2025 144 Filing
Feb 19, 2025 144 Filing
Feb 18, 2025 144 Filing